Concepedia

Author

Philip R. Dormitzer

Pfizer (United States)ORCID

Also Known As

Dormitzer, P. R., Dormitzer, Philip R., Michael Abram, P R Dormitzer, P. R. Dormitzer, P.R. Dormitzer, Philip Dormitzer, Philip R Dormitzer, Philip R. Dormitzer, Philip Ralph Dormitzer

150

Publications

37.3K

Citations

61

H-Index

83

Concepts

All Affiliations

Pfizer (United States)Novartis (United States)The University of Texas Medical Branch at GalvestonBioNTech (Germany)Boston Children's Hospital
PR

About

Philip R. Dormitzer is an author at Pfizer (United States) specializing in medicine, immunology, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

43

9.3K

2

Natural Sciences

8

8

1.4K

3

Engineering

3

3

812

4

Health Sciences

2

2

266

5

Public Health

2

2

113

Philip R. Dormitzer

×

85

Publications

35K

Citations

53

H-Index

YearCitations

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin,

New England Journal of Medicine

2020

15.1K

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey,

New England Journal of Medicine

2020

2.7K

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian,

Nature

2020

2K

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin,

Nature

2020

1.6K

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Robert W. Frenck, Nicola P. Klein, Nicholas Kitchin,

New England Journal of Medicine

2021

913

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

Uğur Şahin, Alexander Muik, Isabel Vogler,

Nature

2021

810

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel, Isis Kanevsky, Ye Che,

Nature

2021

725

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Xuping Xie, Yang Liu, Jianying Liu,

Nature Medicine

2021

670

Nonviral delivery of self-amplifying RNA vaccines

Andrew J. Geall, Ayush Verma, Gillis R. Otten,

Proceedings of the National Academy of Sciences

2012

648

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

Emmanuel B. Walter, Kawsar R. Talaat, Charu Sabharwal,

New England Journal of Medicine

2021

611

Page 1